Late-term results of mitral valve replacement with St. Jude medical® mechanical valve prosthesis: Samsun experience

Acta Cardiologica

Volumn 61, Issue 5, 2006, Pages 537-544

  Demirag, Mustafa Kemal ^a   Keceligil, Hasan Tahsin ^a   Kolbakir, Fersat ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anticoagulation; Cardiac valve replacement; Prosthetic cardiac valve; Prosthetic valve endocarditis; Thromboembolism

Indexed keywords

WARFARIN;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHILD; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOCARDITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATORENAL SYNDROME; HUMAN; INFECTION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MORTALITY; REOPERATION; RHEUMATIC FEVER; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; MYOCARDIAL ISCHEMIA; PROSTHESIS DESIGN; REOPERATION; RHEUMATIC HEART DISEASE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 33750310187     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.5.2017769     Document Type: Article

References (26)

1. Casselman F, Herijgers P, Meyns B, Flameng W, Daenen W. The Bicarbon heart valve prosthesis: short-term results. J Heart Valve Dis 1997; 6: 410-5.
2. Kratz JM, Crawford FA Jr, Sade RM, Crumbley AJ, Stroud MR. St. Jude prosthesis for aortic and mitral valve replacement: a ten-year experience. Ann Thorac Surg 1993; 56: 462-8.
3. Copeland JG. The CarboMedics prosthetic heart valve: a second generation bileaflet prosthesis. Semin Thorac Cardiovasc Surg 1996; 8: 237-41.
4. Westaby S, Van Nooten G, Sharif H, Pillai R, Caes F. Valve replacement with the ATS open pivot bileaflet prosthesis. Eur J Cardiothorac Surg 1996; 10: 660-5.
5. Bodnar E. Mechanical valves. In: Acar J, Bodnar E, ed. Textbook of Acquired Heart Valve Disease. ICR Publishers, London, 1995, p. 965-1001.
6. Kinsley RH, Antunes MJ, Colsen PR. St. Jude Medical valve replacement. An evaluation of valve performance. J Thorac Cardiovasc Surg 1986; 92: 349-60.
7. Demirag M, Kirali K, Omeroglu SN, Mansuroglu D, Akinci E, Ipek G, Berki T, Gurbuz A, Isik O, Yakut C. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves. J Heart Valve Dis 2001; 10: 78-83.
8. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for Reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996; 62: 932-5.
9. Katircioglu F, Yamak B, Battaloglu B, Saritas A, Kiziltepe U, Kural T, Tasdemir O, Bayazit K. Long term results of mitral valve replacement with preservation of the posterior leaflet. J Heart Valve Dis 1996; 5: 302-6.
10. Baudet EM, Oca CC, Roques XF, Laborde MN, Hafez AS, Collot MA, Ghidoni IM. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985; 90: 137-44.
11. Czer LS, Matloff J, Chaux A, DeRobertis M, Yoganathan A, Gray RJ. A 6 year experience with the St. Jude Medical valve: hemodynamic performance, surgical results, biocompatibility and follow-up. J Am Coll Cardiol 1985; 6: 904-12.
12. Remadi JP, Bizouarn P, Baron O, Al Habash O, Despins P, Michaud JL, Duveau D. Mitral valve replacement with the St. Jude Medical prosthesis: a 15-year follow-up. Ann Thorac Surg 1998; 66: 762-7.
13. Hering D, Piper C, Bergemann R, Hillenbach C, Dahm M, Huth C, Horstkotte D. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Chest 2005; 127: 53-9.
14. rd, Stroud MR, Bradley SM, Sade RM, Crawford FA Jr. Twenty-year experience with the St Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003; 126: 2022-31.
15. Chaux A, Czer LS, Matloff JM, DeRobertis MA, Stewart ME, Bateman TM, Kass RM, Lee ME, Gray RJ. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience. J Thorac Cardiovasc Surg 1984; 88: 706-17.
16. Emery RW, Krogh CC, Arom KV, Emery AM, Benyo-Albrecht K, Joyce LD, Nicoloff DM. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005; 79: 776-83.
17. Burckhardt D, Striebel D, Vogt S, Hoffmann A, Roth J, Weiss P, Kiowski W, Pfisterer M, Burkart F, Althaus U. Heart valve replacement with St. Jude Medical valve prosthesis. Long-term experience in 743 patients in Switzerland. Circulation 1988; 78: 118-24.
18. Fernandez J, Laub GW, Adkins MS, Anderson WA, Chen C, Bailey BM, Nealon LM, McGrath LB. Early and late-phase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients. J Thorac Cardiovasc Surg 1994; 107: 394-406.
19. Nakano K, Koyanagi H, Hashimoto A, Kitamura M, Endo M, Nagashima M, Tokunaga H. Twelve years' experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1994; 57: 697-702.
20. Baudet EM, Puel V, McBride JT, Grimaud JP, Roques F, Clerc F, Roques X, Laborde N. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995; 109: 858-70.
21. Isomura T, Hisatomi K, Hirano A, Kosuga K, Ohishi K. The St. Jude Medical prosthesis in the mitral position. Eur J Cardiothorac Surg 1994; 8: 11-4.
22. DiSesa VJ, Collins JJ Jr, Cohn LH. Hematological complications with the St. Jude valve and reduced-dose Coumadin. Ann Thorac Surg 1989; 48: 280-3.
23. Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 suppl 3: 457S-482S.
24. Pruefer D, Dahm M, Dohmen G, Horstkotte D, Bergemann R, Oelert H. Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5). Eur Heart J Supplements 2001; 3 suppl Q: Q39-Q43.
25. Meschengieser SS, Fondevila CG, Frontroth J, Santarelli MT, Lazzari MA. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997; 113: 910-6.
26. Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. J Heart Valve Dis 1999; 8: 665-73.